Hyponatremia and abnormal ingestion of water in catatonia

Primary Psychiatry

Volumn 17, Issue 4, 2010, Pages 29-33

  McDaniel, William W ^a,b   Spiegel, David R ^a  

^a Hampton VA Medical Center   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CITALOPRAM; DEMECLOCYCLINE; FLUOXETINE; FLUPHENAZINE; LITHIUM; LORAZEPAM; MINOCYCLINE; RISPERIDONE; SODIUM; VALPROATE SEMISODIUM; VALPROIC ACID; VASOPRESSIN;

ADULT; AGED; ARTICLE; AUTOMUTILATION; BEDTIME DOSAGE; BIPOLAR DISORDER; CASE REPORT; CATATONIA; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEEDING DISORDER; FEMALE; FLUID INTAKE; HUMAN; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; MALE; MANIA; POLYDIPSIA; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL; STEREOTYPY; URINARY TRACT INFECTION;

EID: 77951749522     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Lee JW, Schwartz JL. Catatonia associated with hyponatremia. Neuropsychiatry Neuropsychol Behav Neurol. 1997;10(1):63-64.
2. Taylor MA, Fink M: Catatonia in psychiatric classification: a home of its own. Am J Psychiatry. 2003;160(7):1233-1241.
3. Taylor MA. Clinical examination. In: Caroff S, Mann S, Francis A, Fricchione G, eds. Catatonia: From Psychopathology to Neurobiology. Washington, DC: American Psychiatric Press; 2004;45-52.
4. Fink M, Taylor MA. Catatonia: A Clinican's Guide to Diagnosis and Treatment. Cambridge, UK: Cambridge University Press; 2003.
5. Losonczy MF, Song JS, Mohs RC, Small NA, Davidson M, Johns CA, Davis KL. Correlates of lateral ventricular size in chronic schizophrenia. 1. Behavioral and treatment response measures. Am J Psychiatry. 1986;143(9):976-981.
6. Taylor MA, Abrams R. Catatonia: prevalence and importance in the manic phase of manic-depressive illness. Arch Gen Psychiatry. 1977;34(10):1223-1225.
7. Abrams R, Taylor MA, Stolorow KA. Catatonia and mania: patterns of cerebral dysfunction. Biol Psychiatry. 1979;14(1):111-117.
8. Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia I: rating scale and standard examination. Acta Psychiatrica Scand. 1996;93(2):129-136.
9. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, text rev. Washington, DC: American Psychiatric Association; 2000.
10. Illowsky BP, Kirch DC. Polydipsia and hyponatremia in psychiatric patients. Am J Psychiatry. 1988;145(8):675-683.
11. Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. 2009;342(21):1581-1589.
12. Yamauchi T, Makinodan M, Nagashima T, Kiuchi K, Noriyama Y, Kishimoto T. Type D Syndrome of inappropriate antidiuretic hormone secretion in a schizophrenia patient with polydipsia. J Brain Dis. 2009;1(1):25-27.
13. Zerbe R, Stropes L, Robertson G, et al. Vasopressin function in the syndrome of inappropriate antidiuresis. Annu Rev Med. 1980;31:315-327.
14. Goldman MB, Luchins DJ, Robertson GL. Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia. N Engl J Med. 1988;318(7):397-403.
15. Northoff G, Ecker J, Fritze J. Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patient with the NMDA antagonist amantadine. J Neurol Neurosurg Psychiatry. 1997;62(4):404-406.
16. Pyner S. Neurochemistry of the paraventricular nucleus of the hypothalamus: implications for cardiovascular regulation. J Chem Neuroanatomy. 2009;38(3):197-208.
17. Bisset GW, Fairhall KM. Release of vasopressin and oxytocin by excitatory amino acid agonists and the effect of antagonists on release by muscarine and hypertonic saline in the rat in vivo. Br J Pharmacol. 1996;117(2):309-314.
18. Bisset GW, Chowdrey HS, Fairhall KM, Gunn LK. Central inhibition by gamma-aminobytyric acid and muscimol of release of vasopressin and oxytocin by an osmotic stimulus in the rat. Br J Pharmacol. 1990;99(3):529-535.
19. Presti MF, Watson CJ, Kennedy RT, Yang M, Lewis MH. Behavior-related alterations of striatal neurochemistry in a mouse model of stereotyped movement disorder. Pharmacol Biochem Behav. 2004;77(3):501-507.
20. Tsunematsu T, Fu LY, Yamanaka A, et al. Vasopressin increases locomotion through a VIa receptor in orexin/hypocretin neurons: implications for water homeostasis. J Neuroscience. 2008;28(1):228-238.
21. Dohanics J, Hoffman GE, Verbalis JG. Chronic hyponatremia reduces survival of magnocellular vasopressin and oxytocin neurons after axonal injury. J Neuroscience. 1996;16(7):2373-2380.
22. Ahuja N, Carroll BT. Possible anti-catatonic effects of minocycline in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(4):968-969.
23. Miyaoka T, Yasukawa R, Yasuda H, Hayashida M, Inagaki T, Horiguchi J. Possible antipsychotic effects of minocycline in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(1):304-307.
24. Miyaoka T, Yasukawa R, Yasuda H, Hayashida M, Inagaki T, Horiguchi J. Minocycline as adjunctive therapy for schizophrenia. Clin Neuropharmacol. 2008;31(5):287-292.
25. Fujita Y, Ishima T, Kunitachi S, et al. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(2):336-339.
26. Alano, CC, Kauppinen TM, Valis AV, Swanson RA. Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proc Natl Acad Sci USA. 2006;103(25):9685-9690.
27. Ferris CF, Melloni RH, Koppel G, Perry KW, Fuller RW, Delville Y. Vasopressin/serotonin interactions in the anterior hypothalamus control aggressive behavior in golden hamsters. J Neuroscience. 1997;17(11):4331-4340.
28. O'Sullivan ST, Reardon CM, McGreal GT, Hehin DJ, Kirwan WO, Brady MP. Deliberate ingestion of foreign bodies by institutionalized psychiatric patients. Ir J Med Sci. 1996;165(4):294-296.